Literature DB >> 18722574

Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies.

Rebecca Troisi1, Kristin Braekke, Nina Kittelsen Harsem, Marianne Hyer, Robert N Hoover, Anne Cathrine Staff.   

Abstract

OBJECTIVE: The objective of the study was to determine whether blood pressure increases are associated with maternal angiogenic factors in uncomplicated and preeclamptic pregnancies. STUDY
DESIGN: Associations of blood pressure increases from mid- to late pregnancy with maternal serum concentrations of soluble fms-like tyrosine kinase receptor (sFlt1), soluble endoglin (sEng), and placental growth factor (PlGF) at delivery were analyzed in 43 uncomplicated and 44 preeclamptic pregnancies.
RESULTS: In uncomplicated pregnancies, increases in diastolic and mean arterial pressure were inversely associated with PlGF at delivery and positively associated with sEng and sFlt1/PlGF ratio. There were no significant associations between blood pressure increases and angiogenic factor concentrations in preeclampsia.
CONCLUSION: These data suggest that angiogenic factors are involved in blood pressure modulation in normotensive pregnancy and are consistent with the hypothesis that angiogenic balance plays a role in maternal breast cancer risk reduction associated with mid- to late blood pressure increases in uncomplicated pregnancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722574      PMCID: PMC2646178          DOI: 10.1016/j.ajog.2008.06.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  27 in total

Review 1.  Preeclampsia: an excessive maternal inflammatory response to pregnancy.

Authors:  C W Redman; G P Sacks; I L Sargent
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

2.  Intrauterine environment and breast cancer risk in women: a population-based study.

Authors:  A Ekbom; C C Hsieh; L Lipworth; H Q Adami; D Trichopoulos
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

3.  Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

Authors:  Myles Wolf; Carl A Hubel; Chun Lam; Marybeth Sampson; Jeffrey L Ecker; Roberta B Ness; Augustine Rajakumar; Ashi Daftary; Alia S M Shakir; Ellen W Seely; James M Roberts; Vikas P Sukhatme; S Ananth Karumanchi; Ravi Thadhani
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

4.  Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women.

Authors:  Kora Hirtenlehner; Jürgen Pollheimer; Cornelia Lichtenberger; Markus F Wolschek; Harald Zeisler; Peter Husslein; Martin Knöfler
Journal:  J Soc Gynecol Investig       Date:  2003-10

5.  Pregnancy characteristics and maternal risk of breast cancer.

Authors:  R Troisi; H A Weiss; R N Hoover; N Potischman; C A Swanson; D R Brogan; R J Coates; M D Gammon; K E Malone; J R Daling; L A Brinton
Journal:  Epidemiology       Date:  1998-11       Impact factor: 4.822

6.  Raised plasma endostatin levels correlate inversely with breast cancer angiogenesis.

Authors:  Swee H Teh; Arnold D K Hill; Adriana W S Lee; Deirdre Foley; Susan Kennedy; Leonie Young; Enda McDermott; Niall O'Higgins
Journal:  J Surg Res       Date:  2004-01       Impact factor: 2.192

Review 7.  The role of angiogenesis in tumor growth.

Authors:  J Folkman
Journal:  Semin Cancer Biol       Date:  1992-04       Impact factor: 15.707

8.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 9.  Pre-eclampsia and the hypertensive disorders of pregnancy.

Authors:  Lelia Duley
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

10.  Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer.

Authors:  F J Hoar; G Y H Lip; F Belgore; P S Stonelake
Journal:  Int J Biol Markers       Date:  2004 Jul-Sep       Impact factor: 3.248

View more
  15 in total

1.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

2.  Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.

Authors:  Stacy Zamudio; Marcus Borges; Lourdes Echalar; Olga Kovalenko; Enrique Vargas; Tatiana Torricos; Abdulla Al Khan; Manuel Alvarez; Nicholas P Illsley
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

3.  Maternal angiogenic profile in pregnancies that remain normotensive.

Authors:  Jessica M Faupel-Badger; Anne Cathrine Staff; Ravi Thadhani; Camille E Powe; Nancy Potischman; Robert N Hoover; Rebecca Troisi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-10       Impact factor: 2.435

4.  Maternal circulating angiogenic factors in twin and singleton pregnancies.

Authors:  Jessica M Faupel-Badger; Thomas F McElrath; Michele Lauria; Lauren C Houghton; Kee-Hak Lim; Samuel Parry; David Cantonwine; Gabriel Lai; S Ananth Karumanchi; Robert N Hoover; Rebecca Troisi
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

5.  Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia.

Authors:  Guixiang Chen; Lihong Zhang; Xiaohong Jin; Yunjiao Zhou; Jianying Niu; Jing Chen; Yong Gu
Journal:  Reprod Sci       Date:  2012-09-18       Impact factor: 3.060

6.  Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.

Authors:  Ingunn M Stefansson; Maria Raeder; Elisabeth Wik; Monica Mannelqvist; Kanthida Kusonmano; Gøril Knutsvik; Ingfrid Haldorsen; Jone Trovik; Anne M Øyan; Karl-H Kalland; Anne Cathrine Staff; Helga B Salvesen; Lars A Akslen
Journal:  Oncotarget       Date:  2015-04-30

7.  Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.

Authors:  Luiza O Perucci; Karina B Gomes; Letícia G Freitas; Lara C Godoi; Patrícia N Alpoim; Melina B Pinheiro; Aline S Miranda; Antônio L Teixeira; Luci M Dusse; Lirlândia P Sousa
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

8.  Maternal reproductive hormones and angiogenic factors in pregnancy and subsequent breast cancer risk.

Authors:  Rosie Cornish; Anne Cathrine Staff; Andy Boyd; Debbie A Lawlor; Steinar Tretli; Gary Bradwin; Thomas F McElrath; Marianne Hyer; Robert N Hoover; Rebecca Troisi
Journal:  Cancer Causes Control       Date:  2018-12-01       Impact factor: 2.506

9.  Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile.

Authors:  L Carbillon
Journal:  Br J Cancer       Date:  2012-10-23       Impact factor: 7.640

10.  Association of Maternal Antiangiogenic Profile at Birth With Early Postnatal Loss of Microvascular Density in Offspring of Hypertensive Pregnancies.

Authors:  Grace Z Yu; Christina Y L Aye; Adam J Lewandowski; Esther F Davis; Cheen P Khoo; Laura Newton; Cheng T Yang; Ayman Al Haj Zen; Lisa J Simpson; Kathryn O'Brien; David A Cook; Ingrid Granne; Theodosios Kyriakou; Keith M Channon; Suzanne M Watt; Paul Leeson
Journal:  Hypertension       Date:  2016-07-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.